These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 34745457)
1. Protein profiling reveals potential isomiR-associated cross-talks among RNAs in cholangiocarcinoma. Guo L; Dou Y; Yang Y; Zhang S; Kang Y; Shen L; Tang L; Zhang Y; Li C; Wang J; Liang T; Li X Comput Struct Biotechnol J; 2021; 19():5722-5734. PubMed ID: 34745457 [TBL] [Abstract][Full Text] [Related]
2. Rewired functional regulatory networks among miRNA isoforms (isomiRs) from let-7 and miR-10 gene families in cancer. Liang T; Han L; Guo L Comput Struct Biotechnol J; 2020; 18():1238-1248. PubMed ID: 32542110 [TBL] [Abstract][Full Text] [Related]
3. Integrative omics analysis reveals relationships of genes with synthetic lethal interactions through a pan-cancer analysis. Guo L; Li S; Qian B; Wang Y; Duan R; Jiang W; Kang Y; Dou Y; Yang G; Shen L; Wang J; Liang T Comput Struct Biotechnol J; 2020; 18():3243-3254. PubMed ID: 33240468 [TBL] [Abstract][Full Text] [Related]
4. Good or not good: Role of miR-18a in cancer biology. Kolenda T; Guglas K; Kopczyńska M; Sobocińska J; Teresiak A; Bliźniak R; Lamperska K Rep Pract Oncol Radiother; 2020; 25(5):808-819. PubMed ID: 32884453 [TBL] [Abstract][Full Text] [Related]
5. Advancing Pan-cancer Gene Expression Survial Analysis by Inclusion of Non-coding RNA. Ye B; Shi J; Kang H; Oyebamiji O; Hill D; Yu H; Ness S; Ye F; Ping J; He J; Edwards J; Zhao YY; Guo Y RNA Biol; 2020 Nov; 17(11):1666-1673. PubMed ID: 31607216 [TBL] [Abstract][Full Text] [Related]
6. PreMSIm: An R package for predicting microsatellite instability from the expression profiling of a gene panel in cancer. Li L; Feng Q; Wang X Comput Struct Biotechnol J; 2020; 18():668-675. PubMed ID: 32257050 [TBL] [Abstract][Full Text] [Related]
7. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers. Wang N; Zhu L; Wang L; Shen Z; Huang X Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736 [TBL] [Abstract][Full Text] [Related]
8. Characterization of Cell Cycle-Related Competing Endogenous RNAs Using Robust Rank Aggregation as Prognostic Biomarker in Lung Adenocarcinoma. Yang Y; Zhang S; Guo L Front Oncol; 2022; 12():807367. PubMed ID: 35186743 [TBL] [Abstract][Full Text] [Related]
9. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures. Zhang X; Wang Y; A G; Qu C; Chen J Front Immunol; 2021; 12():721030. PubMed ID: 34531868 [TBL] [Abstract][Full Text] [Related]
10. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism. Chang S; Yim S; Park H Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981 [TBL] [Abstract][Full Text] [Related]
11. The molecular feature of macrophages in tumor immune microenvironment of glioma patients. Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502 [TBL] [Abstract][Full Text] [Related]
12. Violations of proportional hazard assumption in Cox regression model of transcriptomic data in TCGA pan-cancer cohorts. Zeng Z; Gao Y; Li J; Zhang G; Sun S; Wu Q; Gong Y; Xie C Comput Struct Biotechnol J; 2022; 20():496-507. PubMed ID: 35070171 [TBL] [Abstract][Full Text] [Related]
13. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas. Zhao S; Li Y; Xu J; Shen L Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of tumor necrosis factor-α-inducible protein 8-like 2 (TIPE2): A potential novel pan-cancer immune checkpoint. Bai KH; Zhang YY; Li XP; Tian XP; Pan MM; Wang DW; Dai YJ Comput Struct Biotechnol J; 2022; 20():5226-5234. PubMed ID: 36187930 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of the novel omicron receptor AXL in cancers. Zhang WN; Li XP; Wang PF; Zhu L; Xiao XH; Dai YJ Comput Struct Biotechnol J; 2022; 20():3304-3312. PubMed ID: 35782741 [TBL] [Abstract][Full Text] [Related]
16. A comprehensive analysis of ncRNA-mediated interactions reveals potential prognostic biomarkers in prostate adenocarcinoma. Guo L; Kang Y; Xiong Y; Jia L; Yan X; Xia D; Yu J; Wang J; Liang T Comput Struct Biotechnol J; 2022; 20():3839-3850. PubMed ID: 35891787 [TBL] [Abstract][Full Text] [Related]
17. Identifies microtubule-binding protein Wang W; Zhang J; Wang Y; Xu Y; Zhang S Comput Struct Biotechnol J; 2022; 20():3322-3335. PubMed ID: 35832625 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. Dong R; Liu J; Sun W; Ping W Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160 [TBL] [Abstract][Full Text] [Related]
19. Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis. Gao ZW; Yang L; Liu C; Wang X; Guo WT; Zhang HZ; Dong K Front Immunol; 2022; 13():903461. PubMed ID: 35663977 [TBL] [Abstract][Full Text] [Related]
20. A novel lncRNA-miRNA-mRNA competing endogenous RNA regulatory network in lung adenocarcinoma and kidney renal papillary cell carcinoma. Zhou Q; Li D; Zheng H; He Z; Qian F; Wu X; Yin Z; Bao PT; Jin M Thorac Cancer; 2021 Oct; 12(19):2526-2536. PubMed ID: 34453499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]